Home
/
PURE BIOSCIENCE, INC.
/
Financials
/
Quarterly
PURE BIOSCIENCE, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that PURE BIOSCIENCE, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Jan 31, 2026
$443.0K
Mar 17, 2026
Q1
2026
Oct 31, 2025
$707.0K
Dec 15, 2025
Q3
2025
Apr 30, 2025
$489.0K
Jun 16, 2025
Q2
2026
Jan 31, 2025
$391.0K
Mar 17, 2026
Q1
2026
Oct 31, 2024
$555.0K
Dec 15, 2025
Q3
2025
Apr 30, 2024
$440.0K
Jun 16, 2025
Q2
2025
Jan 31, 2024
$325.0K
Mar 17, 2025
Q1
2025
Oct 31, 2023
$718.0K
Dec 16, 2024
Q3
2024
Apr 30, 2023
$406.0K
Jun 14, 2024
Q2
2024
Jan 31, 2023
$396.0K
Mar 18, 2024
Q1
2024
Oct 31, 2022
$467.0K
Dec 14, 2023
Q3
2023
Apr 30, 2022
$497.0K
Jun 14, 2023
Q2
2023
Jan 31, 2022
$415.0K
Mar 17, 2023
Q1
2023
Oct 31, 2021
$497.0K
Dec 14, 2022
Q3
2022
Apr 30, 2021
$556.0K
Jun 14, 2022
Q2
2022
Jan 31, 2021
$868.0K
Mar 15, 2022
Q1
2022
Oct 31, 2020
$1.42M
Dec 15, 2021
Q3
2012
Apr 30, 2012
$207.0K
Jun 13, 2012
Q2
2012
Jan 31, 2012
$221.0K
Mar 16, 2012
Q3
2012
Apr 30, 2011
$128.0K
Jun 13, 2012
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Jan 31, 2026
$444.0K
Mar 17, 2026
Q1
2026
Oct 31, 2025
$708.0K
Dec 15, 2025
Q3
2025
Apr 30, 2025
$491.0K
Jun 16, 2025
Q2
2026
Jan 31, 2025
$391.0K
Mar 17, 2026
Q1
2026
Oct 31, 2024
$556.0K
Dec 15, 2025
Q3
2025
Apr 30, 2024
$441.0K
Jun 16, 2025
Q2
2025
Jan 31, 2024
$326.0K
Mar 17, 2025
Q1
2025
Oct 31, 2023
$722.0K
Dec 16, 2024
Q3
2024
Apr 30, 2023
$407.0K
Jun 14, 2024
Q2
2024
Jan 31, 2023
$397.0K
Mar 18, 2024
Q1
2024
Oct 31, 2022
$471.0K
Dec 14, 2023
Q3
2023
Apr 30, 2022
$524.0K
Jun 14, 2023
Q2
2023
Jan 31, 2022
$416.0K
Mar 17, 2023
Q1
2023
Oct 31, 2021
$501.0K
Dec 14, 2022
Q3
2022
Apr 30, 2021
$561.0K
Jun 14, 2022
Q2
2022
Jan 31, 2021
$916.0K
Mar 15, 2022
Q1
2022
Oct 31, 2020
$1.59M
Dec 15, 2021
Q3
2021
Apr 30, 2020
$2.22M
Jun 15, 2021
Q2
2020
Jan 31, 2020
$349.0K
Mar 12, 2020
Q1
2021
Oct 31, 2019
$398.0K
Dec 15, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Jan 31, 2026
($785.0K)
Mar 17, 2026
Q1
2026
Oct 31, 2025
($464.0K)
Dec 15, 2025
Q3
2025
Apr 30, 2025
($580.0K)
Jun 16, 2025
Q2
2026
Jan 31, 2025
($798.0K)
Mar 17, 2026
Q1
2026
Oct 31, 2024
($689.0K)
Dec 15, 2025
Q3
2025
Apr 30, 2024
($857.0K)
Jun 16, 2025
Q2
2025
Jan 31, 2024
($1.00M)
Mar 17, 2025
Q1
2025
Oct 31, 2023
($735.0K)
Dec 16, 2024
Q3
2024
Apr 30, 2023
($876.0K)
Jun 14, 2024
Q2
2024
Jan 31, 2023
($1.06M)
Mar 18, 2024
Q1
2024
Oct 31, 2022
($993.0K)
Dec 14, 2023
Q3
2023
Apr 30, 2022
($760.0K)
Jun 14, 2023
Q2
2023
Jan 31, 2022
($702.0K)
Mar 17, 2023
Q1
2023
Oct 31, 2021
($796.0K)
Dec 14, 2022
Q3
2022
Apr 30, 2021
($811.0K)
Jun 14, 2022
Q2
2022
Jan 31, 2021
($595.0K)
Mar 15, 2022
Q1
2022
Oct 31, 2020
($180.0K)
Dec 15, 2021
Q3
2021
Apr 30, 2020
$473.0K
Jun 15, 2021
Q2
2021
Jan 31, 2020
($666.0K)
Mar 15, 2021
Q1
2021
Oct 31, 2019
($1.13M)
Dec 15, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Jan 31, 2026
($683.0K)
Mar 17, 2026
Q1
2026
Oct 31, 2025
($379.0K)
Dec 15, 2025
Q3
2025
Apr 30, 2025
($584.0K)
Jun 16, 2025
Q2
2026
Jan 31, 2025
($725.0K)
Mar 17, 2026
Q1
2026
Oct 31, 2024
($627.0K)
Dec 15, 2025
Q3
2025
Apr 30, 2024
($817.0K)
Jun 16, 2025
Q2
2025
Jan 31, 2024
($964.0K)
Mar 17, 2025
Q1
2025
Oct 31, 2023
($711.0K)
Dec 16, 2024
Q3
2024
Apr 30, 2023
($875.0K)
Jun 14, 2024
Q2
2024
Jan 31, 2023
($1.06M)
Mar 18, 2024
Q1
2024
Oct 31, 2022
($986.0K)
Dec 14, 2023
Q3
2023
Apr 30, 2022
($759.0K)
Jun 14, 2023
Q2
2023
Jan 31, 2022
($940.0K)
Mar 17, 2023
Q1
2023
Oct 31, 2021
($795.0K)
Dec 14, 2022
Q3
2022
Apr 30, 2021
($810.0K)
Jun 14, 2022
Q2
2022
Jan 31, 2021
($594.0K)
Mar 15, 2022
Q1
2022
Oct 31, 2020
($179.0K)
Dec 15, 2021
Q3
2021
Apr 30, 2020
$474.0K
Jun 15, 2021
Q2
2021
Jan 31, 2020
($663.0K)
Mar 15, 2021
Q1
2021
Oct 31, 2019
($1.13M)
Dec 15, 2020